GSK plc
GSK
$46.63
-$0.47-1.00%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.44B | 4.96B | 5.79B | 5.42B | 4.31B |
| Total Receivables | 11.16B | 10.55B | 9.69B | 8.23B | 10.54B |
| Inventory | 8.22B | 8.32B | 7.75B | 7.10B | 7.93B |
| Prepaid Expenses | -- | -- | -- | 488.25M | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 153.24M | 390.46M | 127.91M | 46.32M | 403.43M |
| Total Current Assets | 23.98B | 24.21B | 23.37B | 21.28B | 23.18B |
|
|
|||||
| Total Current Assets | 23.98B | 24.21B | 23.37B | 21.28B | 23.18B |
| Net Property, Plant & Equipment | 13.62B | 13.59B | 12.88B | 12.61B | 13.03B |
| Long-term Investments | 9.57B | 9.23B | 8.95B | 8.74B | 8.95B |
| Goodwill | 9.57B | 9.23B | 8.95B | 8.74B | 8.95B |
| Total Other Intangibles | 22.67B | 21.07B | 21.01B | 19.42B | 20.12B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 11.16B | 11.76B | 10.90B | 10.85B | 11.03B |
| Total Assets | 82.45B | 81.19B | 78.43B | 74.44B | 77.80B |
|
|
|||||
| Total Accounts Payable | 19.96B | 18.70B | 17.88B | 4.33B | 18.06B |
| Total Accrued Expenses | -- | -- | -- | 5.08B | -- |
| Short-term Debt | 721.83M | 376.76M | 275.20M | -- | 219.81M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.12B | 2.43B | 2.25B | 2.94B | 3.55B |
| Total Finance Division Other Current Liabilities | 4.88B | 6.41B | 6.50B | 14.81B | 6.93B |
| Total Other Current Liabilities | 4.88B | 6.41B | 6.50B | 14.81B | 6.93B |
| Total Current Liabilities | 28.68B | 27.92B | 26.91B | 27.16B | 28.76B |
|
|
|||||
| Total Current Liabilities | 28.68B | 27.92B | 26.91B | 27.16B | 28.76B |
| Long-Term Debt | 20.02B | 20.97B | 21.28B | 17.16B | 17.75B |
| Short-term Debt | 721.83M | 376.76M | 275.20M | -- | 219.81M |
| Capital Leases | -- | -- | -- | 1.17B | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 12.58B | 12.63B | 12.59B | 12.57B | 13.26B |
| Total Liabilities | 61.28B | 61.52B | 60.79B | 58.06B | 59.77B |
|
|
|||||
| Common Stock & APIC | 6.50B | 6.62B | 6.24B | 6.04B | 6.46B |
| Retained Earnings | 13.46B | 12.05B | 10.73B | 10.98B | 10.97B |
| Treasury Stock & Other | 1.74B | 1.59B | 1.31B | 103.91M | 1.34B |
| Total Common Equity | 21.71B | 20.26B | 18.29B | 17.12B | 18.77B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 21.71B | 20.26B | 18.29B | 17.12B | 18.77B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -532.30M | -598.71M | -649.88M | -732.38M | -743.87M |
| Total Equity | 21.17B | 19.67B | 17.64B | 16.38B | 18.03B |
|
|
|||||